The use of the R programming language has seen exponential growth across industries, with its role being especially pronounced in the pharmaceutical sector. Japan stands out in this growth narrative, thanks in part to the initiatives of the Japan Pharmaceutical Manufacturers Association (JPMA). Before diving into the webinar insights, understanding JPMA’s profound influence and contributions is essential.
About JPMA
Established in 1968, JPMA is a voluntary consortium of 71 research-centric pharmaceutical firms. With its core mission of “realizing patient-oriented healthcare,” JPMA has tirelessly worked towards enhancing global healthcare through the formulation of pioneering ethical drugs.
Summary of the Webinar’s Concept
The Adoption of R in Japan’s Pharma Industry talk and panel discussion will be led by key industry experts from the JPMA R Task Force Team. The webinar explores the usage and adoption of the R in the pharmaceutical industry, specifically focusing on the findings of the JPMA Drug Evaluation Committee, R Task Force Team, and the JPMA Report. The report references various open source works and publications, including those from the R Consortium pilot submissions, Package Validation Hub, and webinar training.
Agenda of the Webinar:
- General Background (10-15 minutes)
- PMDA: Highlighting the intricacies of submissions with R.
- JPMA R Task Force: Delving into past activities and shedding light on future initiatives.
- JPMA Survey Report (15-20 minutes)
- Background: Understanding the rationale and motivation behind the JPMA survey.
- Results: Discuss key findings and their implications for the industry.
- Q&A Session (15 minutes)
Date and Time: Tues, Jan 9, 2024 at 9:00 am JST / Jan 8, 2024 at 4:00 pm PT / 7:00 pm ET
Conclusion:
Under the auspices of JPMA’s guiding principles, the webinar will present a comprehensive glimpse into R’s evolving role in Japan’s pharmaceutical landscape. The dedication of JPMA, combined with the increasing relevance of R, signifies an exciting chapter in the pharmaceutical domain’s data-driven journey.
Join the JPMA webinar to learn more about R’s pharmaceutical achievements!